Analysis of Plasma Epstein-Barr Virus DNA in Nasopharyngeal Cancer After Chemoradiation to Identify High-Risk Patients for Adjuvant Chemotherapy: A Randomized Controlled Trial.
暂无分享,去创建一个
A. King | A. Ahuja | K. C. Chan | E. Hui | F. Mo | D. Poon | M. Tong | A. Chan | B. Zee | B. Ma | V. Lee | W. Ng | R. Ngan | F. Wong | S. Tung | Y. Lo | H. Loong | A. Cheng | Hoi-Ching Cheng | Ki Wang
[1] Kelly Y. Kim,et al. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients. , 2017, International journal of radiation oncology, biology, physics.
[2] Ying Sun,et al. Adjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: Long-term results of a phase 3 multicentre randomised controlled trial. , 2017, European journal of cancer.
[3] Kelly Y. Kim,et al. Current State of PCR-Based Epstein-Barr Virus DNA Testing for Nasopharyngeal Cancer. , 2017, Journal of the National Cancer Institute.
[4] Jin-Ching Lin,et al. Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA , 2016, Oncotarget.
[5] A. Massie,et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. , 2016, Blood.
[6] Y. Shih,et al. Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid. , 2014, International journal of radiation oncology, biology, physics.
[7] Hung-Ming Wang,et al. Clinical scenario of EBV DNA follow-up in patients of treated localized nasopharyngeal carcinoma. , 2013, Oral oncology.
[8] T. Mok,et al. Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma. , 2005, Journal of the National Cancer Institute.
[9] S. Leung,et al. Plasma Epstein-Barr virus DNA and residual disease after radiotherapy for undifferentiated nasopharyngeal carcinoma. , 2002, Journal of the National Cancer Institute.